Adult T Cell Leukemia (ATL) Terminated Phase 2 Trials for Denileukin diftitox (DB00004)

Also known as: Adult T-Cell Leukemia (ATL) / T Cell Leukemia, Adult / Adult T Cell Leukemia / Leukemia, Adult T-Cell / Adult T-Cell Leukemia

IndicationStatusPhase
DBCOND0040418 (Adult T Cell Leukemia (ATL))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00117845Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell LeukemiaTreatment